Results 81 to 90 of about 4,881 (174)

RNase1-driven ALK-activation is an oncogenic driver and therapeutic target in non-small cell lung cancer. [PDF]

open access: yesSignal Transduct Target Ther
Zha Z   +24 more
europepmc   +1 more source

Cytotoxicity and Binding to DNA, Lysozyme, Ribonuclease A, and Human Serum Albumin of the Diiodido Analog of Picoplatin. [PDF]

open access: yesInorg Chem
Ferraro G   +7 more
europepmc   +1 more source

Gemcitabine resistance by CITED4 upregulation via the regulation of BIRC2 expression in pancreatic cancer. [PDF]

open access: yesJ Biomed Sci
Jeong EJ   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy